Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
For the earlier window mild cognitive impairment (MCI) and brain aging where synaptic loss is the dominant driver of symptoms and where the 2026 NICE rejection of lecanemab and donanemab has left a substantial UK treatment gap, the synaptic-rationale conversation continues even after the fosgonimeton failure
Having a way to measure brain ageing with a home test kit from a pin prick of blood, means we can realistically see what the impact of specific diet changes and antioxidant supplements might be
Though GHK-Cu delivers minimal copper per dose and the peptide controls copper release, extended use warrants verification that copper homeostasis remains normal
D.ChunE.RobertsonL.GlickmanJ
US$ 25.04
US$ 21.37
US$ 23.21
US$ 20.68
US$ 25.43
US$ 20.98
US$ 26.43
